@aptose.com
Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
About
Description
Aptose Biosciences is a clinical-stage biotechnology company dedicated to developing personalized therapies to address unmet medical needs in oncology. With a focus on hematologic malignancies, Aptose is building a pipeline of novel and targeted oncology therapies to serve specific populations of cancer patients. Their products aim to provide single agent efficacy and enhance the effectiveness of conventional anti-cancer treatments by targeting key drivers of disease in cancer cells without overlapping toxicities.
This approach preserves the quality of life in cancer patients. Aptose's product pipeline includes Tuspetinib, an oral myeloid kinase inhibitor, and Luxeptinib, an oral lymphoid and myeloid kinase inhibitor. Both products are currently in clinical trials for various hematologic malignancies.
Aptose's leadership team consists of distinguished individuals with a unique blend of academic and industry experience, bringing valuable expertise to their research and development efforts
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories